anagrelide
Generic: ANAGRELIDE HYDROCHLORIDE·Brand: AGRYLIN, ANAGRELIDE HYDROCHLORIDE, Agrylin
anagrelide: 1 clinical trial tracked.
anagrelide evidence translation
What we can confirm
1 tracked trial
No verified listed developer
What it means
AI will separate confirmed drug evidence from unknown company context.
What to watch
Watch trial status, endpoints, and the next source-backed update.
BioSniper AIPage evidence connected
Prepared research question
What is verified about anagrelide, and what remains unknown?
Run cited research
Traceable citations · Unknowns marked
See linked entities and source evidence1 indications · 0 study sponsors
Related indications
Study sponsors
No additional listed-company sponsor is linked.
Clinical Trials (1)
A Phase 3, Randomized, Open-label, Active-Comparator-Controlled Clinical Study to Evaluate the Safety and Efficacy of Bomedemstat (MK-3543/IMG-7289) Versus Best Available Therapy (BAT) in Participants With Essential Thrombocythemia Who Have an Inadequate Response to or Are Intolerant of Hydroxyurea
Primary endpoint: Durable Clinicohematologic Response (DCHR) Rate
InterventionalRandomizedsingle340 targetStarted 2023-12Completion 2028-0850 sites · Argentina, Australia, Belgium, Canada…Merck Sharp & Dohme LLC